Myriad Genetics

(NASDAQ) MYGN

Current Price$4.95

Market Cap$448.84M

Since IPO (1995)-6%

5 Year-84%

1 Year-33%

1 Month+5%

Myriad Genetics Financials at a Glance

Market Cap

$448.84M

Revenue (TTM)

$824.50M

Net Income (TTM)

$365.90M

EPS (TTM)

$-3.95

P/E Ratio

-1.21

Dividend

$0.00

Beta (Volatility)

1.35 (Average)

Dividend

$0.00

Beta (Volatility)

1.35 (Average)

Price

$4.95

Volume

70,718

Open

$4.84

Price

$4.95

Volume

70,718

Open

$4.84

Previous Close

$4.95

Daily Range

$4.78 - $4.96

52-Week Range

$3.76 - $8.59

Dividend

$0.00

Beta (Volatility)

1.35 (Average)

Price

$4.95

Volume

70,718

Open

$4.84

Previous Close

$4.95

Daily Range

$4.78 - $4.96

52-Week Range

$3.76 - $8.59

MYGN News

Should You Buy These 2 Prenatal Testing Stocks?

David HaenFeb 29, 2020

Myriad Genetics CEO Mark Capone Resigns

Taylor CarmichaelFeb 7, 2020

Why Myriad Genetics Shares Are Tanking Today

Keith SpeightsFeb 7, 2020

Page 1

MYGN: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Myriad Genetics

Industry

Biotechnology

Sector

Health Care

Employees

2,700

CEO

Samraat S Raha, MBA

Website

www.myriad.com

Headquarters

Salt Lake City, UT 84108, US

MYGN Financials

Key Financial Metrics (TTM)

Gross Margin

70%

Operating Margin

-32%

Net Income Margin

-44%

Return on Equity

-68%

Return on Capital

-46%

Return on Assets

-52%

Earnings Yield

-82.64%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$448.84M

Shares Outstanding

93.51M

Volume

70.72K

Avg. Volume

1.71M

Financials (TTM)

Gross Profit

$576.60M

Operating Income

$139.30M

EBITDA

$397.40M

Operating Cash Flow

$1.80M

Capital Expenditure

$0.00

Free Cash Flow

$1.80M

Cash & ST Invst.

$149.60M

Total Debt

$209.80M

Myriad Genetics Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q4 2025YOY CHG

Revenue

$209.80M

-0.4%

Gross Profit

$146.80M

-2.7%

Gross Margin

69.97%

N/A

Market Cap

$448.84M

N/A

Market Cap/Employee

$166.24K

N/A

Employees

2,700

N/A

Net Income

$7.90M

+81.4%

EBITDA

$60.00M

-154.2%

Quarterly Fundamentals

Name

Q4 2025YOY CHG

Net Cash

$60.20M

-58.8%

Accounts Receivable

$115.30M

-4.9%

Inventory

$30.60M

+11.3%

Long Term Debt

$202.90M

+59.1%

Short Term Debt

$6.90M

-46.1%

Return on Assets

-51.78%

N/A

Return on Invested Capital

-45.65%

N/A

Free Cash Flow

$10.60M

+1414.3%

Operating Cash Flow

$10.60M

+60.6%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

FLGTFulgent Genetics, Inc.

FLGTFulgent Genetics, Inc.$15.12+7.01%

EVHEvolent Health, Inc.

EVHEvolent Health, Inc.$3.99+6.40%

PSNLPersonalis, Inc.

PSNLPersonalis, Inc.$5.90+2.08%

DNAGinkgo Bioworks Holdings, Inc.

DNAGinkgo Bioworks Holdings, Inc.$9.91+2.16%

CSTLCastle Biosciences, Inc.

CSTLCastle Biosciences, Inc.$25.52+2.86%

AMNAMN Healthcare Services, Inc.

AMNAMN Healthcare Services, Inc.$20.72-1.89%

DRIODarioHealth Corp.

DRIODarioHealth Corp.$7.45+2.05%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

NOKNokia

NOKNokia$13.14-0.01%

INTCIntel

INTCIntel$95.78-0.04%

CNSPCns Pharmaceuticals

CNSPCns Pharmaceuticals$7.84+2.39%

GBTGGlobal Business Travel Group

GBTGGlobal Business Travel Group$9.34+0.58%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$13.18+0.01%

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF$5.69-0.00%

IBITiShares Bitcoin Trust

IBITiShares Bitcoin Trust$45.40+0.02%

Questions About MYGN

What is the current price of Myriad Genetics?

Myriad Genetics is trading at $4.95 per share.

What is the 52-week range for Myriad Genetics?

Over the past 52 weeks, Myriad Genetics has traded between $3.76 and $8.59.

How much debt does Myriad Genetics have?

As of the most recent reporting period, Myriad Genetics reported total debt of $209.80M.

How much cash does Myriad Genetics have on hand?

Myriad Genetics reported $149.60M in cash and cash equivalents in its most recent financial results.

What is Myriad Genetics’s dividend yield?

Myriad Genetics does not currently have a dividend yield.

Myriad Genetics

Myriad Genetics Financials at a Glance

MYGN News

Myriad Genetics (MYGN) Q2 Revenue Up 6%

Why Shares of Myriad Genetics Dropped 24% This Week

COVID-19 Pandemic Wreaks Havoc on Myriad Genetics' Fiscal Q4 Results

Here's Why Myriad Genetics Is Tumbling Today

Genetic Testing Stocks Rise Again as Volatility Continues

Should You Buy These 2 Prenatal Testing Stocks?

Myriad Genetics CEO Mark Capone Resigns

Why Myriad Genetics Shares Are Tanking Today

MYGN: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Myriad Genetics

MYGN Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Myriad Genetics Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About MYGN

What is the current price of Myriad Genetics?

What is the 52-week range for Myriad Genetics?

How much debt does Myriad Genetics have?

How much cash does Myriad Genetics have on hand?

What is Myriad Genetics’s dividend yield?

Premium Investing Services